Take Your Trading To The Next Level. Get Started Here!

Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million

September 29, 2023 Comments Off

The data demonstrates the rush by companies to capture new customers after months of hype around Novo Nordisk’s Ozempic and Wegovy.